TICKERNERD
Menu
HQYHQYHealthcare · Health Information Services

HQY Stock Forecast: HealthEquity, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$105
−0.81% on the day

The 15 Wall Street analysts covering HealthEquity, Inc. hold a median 12-month price target of $120 — +14.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 95 of 100 as at 13 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$8.9B
Ticker Nerd rank
95 / 100
Median analyst target
$120
Analysts covering
15
Total return, dividends reinvested
1W
+0.1%
1M
+10.8%
YTD
+14.3%
1Y
+19.8%
From 52W high
−1.9%
From 52W low
+43.1%
$73
$107
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HQY stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores HealthEquity, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 13 Aug 2026
95 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
96
Volatility
95
Accruals
87
Revisions
82
Quality
82
Momentum
67
Value
66
Growth
57
Size
17

Issuance (96): The share count has been shrinking and the company is not leaning on new borrowing.

Growth (57): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (17): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HQY stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HQY, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$60$80$100$120$140Oct 25Jan 26Apr 26Jul 26HQYHigh $135Median $120Low $105

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says15 analysts
15 Buy0 Hold0 Sell
Low $105Median $120High $135

The green dot is the last close — the median target sits +14.6% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
24 July 2026BTIGMaintainsBuy$110 → $115
24 July 2026BTIGMaintainsBuy—
3 June 2026RBC CapitalReiteratesOutperform$108
3 June 2026RBC CapitalReiteratesOutperform—
1 June 2026CitizensMaintainsMarket Outperform$110 → $111
1 June 2026CitizensMaintainsMarket Outperform—
29 May 2026RBC CapitalMaintainsOutperform$100 → $108
29 May 2026RBC CapitalMaintainsOutperform—
22 May 2026Barrington ResearchMaintainsOutperform—
9 Apr 2026BMO CapitalUpgradeOutperform—
19 Mar 2026Deutsche BankMaintainsBuy—
18 Mar 2026Barrington ResearchMaintainsOutperform—
18 Mar 2026JP MorganMaintainsOverweight—
18 Mar 2026RBC CapitalMaintainsOutperform—
18 Feb 2026BarclaysMaintainsOverweight—
17 Feb 2026BTIGMaintainsBuy—
9 Jan 2026Goldman SachsDowngradeSell—
8 Jan 2026KeybancMaintainsOverweight—
9 Dec 2025BarclaysInitiatesOverweight—
4 Dec 2025Barrington ResearchMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HQY appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

HQY analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+2.0%
Analysts raising
3
Analysts cutting
2
Fundamentals

HealthEquity, Inc. (HQY) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
39.7×

Cheaper than 20% of US stocks

Price / sales
6.6×

Cheaper than 20% of US stocks

Price / book
4.3×

Cheaper than 25% of US stocks

EV / EBITDA
19.0×

Cheaper than 17% of US stocks

Growth & margins
Revenue growth (YoY)
7.2%

Higher than 45% of US stocks

Earnings growth (YoY)
28.8%

Higher than 66% of US stocks

Gross margin
72.3%

Higher than 85% of US stocks

Operating margin
29.3%

Higher than 87% of US stocks

Net margin
17.3%

Higher than 80% of US stocks

Returns & dividend
Return on equity
11.1%

Higher than 66% of US stocks

Return on assets
6.5%

Higher than 83% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

HQY vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
HQYHealthEquity, Inc.$8.9B
95
TEMTempus AI, Inc.$9.7B
25
TXG10X Genomics, Inc.$7.2B
94
BTSGBrightSpring Health Services, Inc.$11.7B
92
HNGEHinge Health, Inc.$6.8B
83
DOCSDoximity, Inc.$4.9B
62
WAYWaystar Holding Corp.$4.8B
36

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own HealthEquity, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HQY news & analysis

HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule

GlobeNewsWire · 3 Aug 2026neutral

HealthEquity announced it will release its fiscal 2027 second-quarter financial results before market open on Thursday, August 27, 2026, and will host an investor conference call at 8:30 a.m. Eastern Time that same day to review the results.

Why it matters — The announcement gives HealthEquity watchers the scheduled date and time to access the company's upcoming quarterly financial results and management commentary.

HealthEquity (HQY) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Investment Research · 3 Aug 2026positive

HealthEquity (HQY) was upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.

Why it matters — An upgrade to Buy suggests increased confidence in HealthEquity's near-term earnings outlook, which could influence investor sentiment.

HealthEquity's Earnings Momentum Deserves More Credit

Seeking Alpha · 27 July 2026positive

Seeking Alpha reported that HealthEquity is consistently beating revenue and EPS expectations with strong operational execution, and guided fiscal 2027 revenue to $1.41–$1.42 billion with robust HSA asset growth, margin expansion, and accelerating buybacks.

Why it matters — HQY watchers would care because the article highlights sustained earnings momentum, resilient custodial yield supported by rate locks through 2029, and cost efficiencies from automation and AI investments.

FAQ

Frequently asked questions about HQY stock

What is the HQY stock price forecast for 2026-2027?

The 15 Wall Street analysts covering HealthEquity, Inc. have a median 12-month price target of $120, with estimates ranging from $105 to $135. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HQY stock a buy right now?

Of the 15 analysts covering HealthEquity, Inc., 15 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks HealthEquity, Inc. 95 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HQY?

As at 13 Aug 2026, HealthEquity, Inc. ranks 95 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (96 of 100).

Will HQY stock go up?

No one can know that. What the data says: the median 12-month target from 15 analysts implies +14.6% from the last close, and Ticker Nerd's factor model ranks HealthEquity, Inc. 95 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HQY stock forecast for 2030?

No analyst covering HealthEquity, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HQY are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $105 to $135 over the next 12 months.

How has HQY stock performed over the past year?

HealthEquity, Inc. returned +19.8% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does HealthEquity, Inc. do?

HealthEquity Inc. is a technology-enabled services platform that empowers consumers, employers, and health plans to manage healthcare savings and spending decisions.

What is the latest news on HQY?

The most recent item we track (GlobeNewsWire, 3 Aug 2026): "HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule". HealthEquity announced it will release its fiscal 2027 second-quarter financial results before market open on Thursday, August 27, 2026, and will host an investor conference call at 8:30 a.m. Eastern Time that same day to review the results.

Company

About HealthEquity, Inc.

HealthEquity Inc. is a technology-enabled services platform that empowers consumers, employers, and health plans to manage healthcare savings and spending decisions. It specializes in administering health savings accounts (HSAs), serving as a non-bank HSA trustee designated by the IRS, along with flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and pre-tax commuter benefits. The company provides investment platforms, online automated advisory services, payment processing, personalized benefit information, and wellness incentives to help users grow tax-advantaged savings. HealthEquity Inc. also offers Consolidated Omnibus Budget Reconciliation Act (COBRA) continuation services and consumer-directed benefits, facilitating efficient healthcare expense management. Its integrated solutions support a wide range of clients in the healthcare and financial services sectors, streamlining benefits administration and enhancing consumer control over health-related finances. Founded in 2002 and headquartered in Draper, Utah, HealthEquity Inc. plays a key role in the growing market for consumer-driven healthcare accounts.

CEO Mr. Scott R. Cutler J.D. · 2,814 employees · United States · https://www.healthequity.com